Psoriasiform Drug Eruption due to AbataceptKATO, Kohei; SATOH, Takahiro; NISHIZAWA, Aya et al.Acta dermato-venereologica. 2011, Vol 91, Num 3, pp 362-363, issn 0001-5555, 2 p.Article

Éruption paradoxale psoriasiforme induite par l'abatacept (ORENCIA^®) = Paradoxical psoriasiform eruption due to abatacept (ORENCIA^®)SCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 12, pp 871-872, issn 0151-9638, 2 p.Article

Abatacept-Induced PsoriasisSILVERMAN, David; OLIVER, Alyce.Cutis (New York, NY). 2011, Vol 88, Num 3, pp 117-118, issn 0011-4162, 2 p.Article

Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE studyCLARK KEYSTONE, Edward; KREMER, Joel M; GUJRATHI, Sheila et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 6, pp 857-861, issn 0003-4967, 5 p.Article

L'abatacept: 1^er modulateur sélectif de la costimulation des lymphocytes TMARIETTE, Xavier.La Lettre du rhumatologue. 2009, Num JUIL, pp 4-6, issn 0761-5027, 3 p., NS-BIBLIOArticle

Abatacept treatment for rheumatoid arthritisSCHIFF, Michael.Rheumatology (Oxford. Print). 2011, Vol 50, Num 3, pp 437-449, issn 1462-0324, 13 p.Article

Selective Costimulation Modulation with Abatacept: A Look at Quality-of-Life Outcomes in Patients with Rheumatoid ArthritisSHERGY, William J.Seminars in arthritis and rheumatism. 2009, Vol 38, Num 6, pp 434-443, issn 0049-0172, 10 p.Article

The clinical utility of inhibiting CD28-mediated costimulationLINSLEY, Peter S; NADLER, Steven G.Immunological reviews. 2009, Vol 229, pp 307-321, issn 0105-2896, 15 p.Article

Effect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetesWEINBERG, Adriana; BOULWARE, David; DIGHERO, Bonnie et al.Vaccine. 2013, Vol 31, Num 42, pp 4791-4794, issn 0264-410X, 4 p.Article

Abatacept is a Promising Treatment for Patients with Disseminated Morphea Profunda: Presentation of Two CasesSTAUSBØL-GRØN, Birgitte; OLESEN, Anne B; DELEURAN, Bent et al.Acta dermato-venereologica. 2011, Vol 91, Num 6, pp 686-688, issn 0001-5555, 3 p.Article

An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials : similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measuresPINCUS, T; BERGMAN, M. J; YAZICI, Y et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 3, pp 345-349, issn 1462-0324, 5 p.Article

Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritisCHOY, E. H.Clinical and experimental rheumatology (Testo stampato). 2009, Vol 27, Num 3, pp 510-518, issn 0392-856X, 9 p.Article

Abatacept : A Novel Treatment for Moderate-to-Severe Rheumatoid ArthritisREYNOLDS, Jennifer; SHOJANIA, Kam; MARRA, Carlo A et al.Pharmacotherapy. 2007, Vol 27, Num 12, pp 1693-1701, issn 0277-0008, 9 p.Article

Abatacept in B7-1―Positive Proteinuric Kidney DiseaseYU, Chih-Chuan; FORNONI, Alessia; CAMPBELL, Kirk N et al.The New England journal of medicine. 2013, Vol 369, Num 25, pp 2416-2423, issn 0028-4793, 8 p.Article

Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationWENINK, M. H; SANTEGOETS, K. C. M; PLATT, A. M et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 1, pp 80-83, issn 0003-4967, 4 p.Article

Subcutaneous Abatacept Versus Intravenous Abatacept = A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to MethotrexateGENOVESE, M. C; COVARRUBIAS, A; LEGERTON, C et al.Arthritis and rheumatism. 2011, Vol 63, Num 10, pp 2854-2864, issn 0004-3591, 11 p.Article

Abatacept in spondyloarthritis refractory to tumour necrosis factor oc inhibitionOLIVIERI, I; D'ANGELO, S; MENNILLO, G. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 1, pp 153-154, issn 0003-4967, 2 p.Article

Réactivation d'un psoriasis cutané sous traitement par abatacept chez une patiente présentant une spondylarthropathieFLORENT, Amélie; ALBERT, Christine; GIACCHERO, Damien et al.Revue du rhumatisme (Ed. française). 2011, Vol 78, Num 1, pp 94-95, issn 1169-8330, 2 p.Article

Validation of a simple activity participation measure for rheumatoid arthritis clinical trialsLI, T; WELLS, G; WESTHOVENS, R et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 2, pp 170-175, issn 1462-0324, 6 p.Article

Abatacept binds to the fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicityDAVIS, Patricia M; ABRAHAM, Ralph; LINDA XU et al.Journal of rheumatology. 2007, Vol 34, Num 11, pp 2204-2210, issn 0315-162X, 7 p.Article

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trialWESTHOVENS, R; COLE, J. C; LI, T et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 10, pp 1238-1246, issn 1462-0324, 9 p.Article

Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritisKLIWINSKI, C; KUKRAL, D; POSTELNEK, J et al.Journal of autoimmunity (Print). 2005, Vol 25, Num 3, pp 165-171, issn 0896-8411, 7 p.Conference Paper

Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis: Longterm Data from the ACQUIRE TrialGENOVESE, Mark C; TENA, César Pacheco; LEGERTON, Clarence William et al.Journal of rheumatology. 2014, Vol 41, Num 4, pp 629-639, issn 0315-162X, 11 p.Article

Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomised clinical trial dataYAZICI, Y; MONIZ REED, D; KLEM, C et al.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 3, pp 494-499, issn 0392-856X, 6 p.Article

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of lifeEMERY, Paul; KOSINSKI, Mark; LI, Tracy et al.Journal of rheumatology. 2006, Vol 33, Num 4, pp 681-689, issn 0315-162X, 9 p.Article